<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: There are differences in outcomes in blacks compared with whites with lymph node-negative (pN0) <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Recurrence in pN0 patients suggests the presence of occult <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastases</z:e> undetected by conventional approaches </plain></SENT>
<SENT sid="2" pm="."><plain>This study explores the association of racial differences in outcomes with occult <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> burden in regional lymph nodes </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: Lymph nodes (range, 2-159) from 282 prospectively enrolled pN0 <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> patients followed for a median of 24 months (range, 2-63 months) were subjected to molecular analysis </plain></SENT>
<SENT sid="4" pm="."><plain>Occult <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> burden was estimated by quantifying the expression of GUCY2C, a biomarker for <z:e sem="disease" ids="C0948380" disease_type="Neoplastic Process" abbrv="">metastatic colorectal cancer</z:e> cells </plain></SENT>
<SENT sid="5" pm="."><plain>Risk categories defined using occult <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> burden was the primary outcome measure </plain></SENT>
<SENT sid="6" pm="."><plain>Association of prognostic variables and risk were defined by multivariate polytomous logistic regression </plain></SENT>
<SENT sid="7" pm="."><plain>RESULTS: Occult <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> burden stratified this cohort of 259 whites and 23 blacks into categories with low (60%; recurrence rate [RR] = 2.3%; 95% confidence interval [CI], 0.1%-4.5%), intermediate (31%; RR = 33.3%; 95% CI, 23.7%-44.1%), and high (9%; RR = 68.0%; 95% CI, 46.5%-85.1%; P &lt; .001) risk </plain></SENT>
<SENT sid="8" pm="."><plain>Blacks compared with whites exhibited 4-fold greater occult <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastases</z:e> in individual lymph nodes (P &lt; .001) </plain></SENT>
<SENT sid="9" pm="."><plain>Multivariate analysis revealed that race (P = .02), T stage (P = .02), and number of lymph nodes collected (P = .003) were independent prognostic markers of risk category </plain></SENT>
<SENT sid="10" pm="."><plain>Blacks compared with whites were more likely to harbor levels of occult <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> burden, associated with the highest recurrence risk (adjusted odds ratio = 5.08; 95% CI, 1.69-21.39; P = .007) </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSIONS: Racial disparities in stage-specific outcomes in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> are associated with differences in occult <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> burden in regional lymph nodes </plain></SENT>
</text></document>